This inventor holds 1 USPTO granted patent. Top assignee: Merz+co. Gmbh & Co.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovations of Inventor Josef Strohmeier
Introduction
Josef Strohmeier, an accomplished inventor based in Alzenauhorstein, Germany, has made significant contributions to the field of pharmaceuticals. With one notable patent to his name, he demonstrates a commitment to advancing medical science through innovative solutions.
Latest Patents
Strohmeier holds a patent for "New BHT ether compounds and their use as hypolipidemic and - Pharmaceutically-active BHT-omega pyridyl ethers of the formula selected from BHT-omega-pyridyl ether compounds." This invention showcases his ingenuity in developing BHT-omega-pyridyl ether compounds that are beneficial for medical applications.
Career Highlights
Currently, Josef Strohmeier is employed at Merz & Co. GmbH & Co., where he continues to explore new ideas and technologies in pharmaceutical research. His work focuses on enhancing drug efficacy and developing new therapeutic approaches.
Collaborations
Throughout his career, Strohmeier has collaborated with notable colleagues, including Markus R. Gold and Panayiotis Jarglis. These partnerships have likely enriched his research endeavors and contributed to the development of innovative pharmaceutical solutions.
Conclusion
Josef Strohmeier exemplifies the spirit of innovation in the pharmaceutical industry. His patent for BHT-omega-pyridyl ether compounds marks a significant achievement in his career, while his collaborations suggest a strong professional network dedicated to scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile